About Zuellig Pharma
Zuellig Pharma is a Healthcare company based in Singapore (Singapore) founded in 1992. Healthcare access in Asia is enhanced by Zuellig Pharma. It operates on a B2B2C and Managed Services model. Zuellig Pharma has completed 4 acquisitions, including Alliance Pharma Cambodge, Klinify and MiCare. Its chief executive, as recorded, is John Graham. Its website zuelligpharma.com draws about 70 thousand monthly visits. Its Indian entity Zuellig Pharma Specialty Solutions (India) Private Limited reported revenue of ₹11.78 Cr. Zuellig Pharma offers products and services including eZRx+, Clinical Trial Support, and Patient Care Solutions. Its focus areas include Pharmaceuticals, Distribution and Logistics, Medical Technology and Clinical Trial Support.
Company details
Healthcare access across Asia is facilitated by Zuellig Pharma through integrated solutions. The company operates in pharmaceuticals, medical devices, consumer healthcare, vaccines, animal health, and specialty care. Innovative distribution, commercialization, clinical trial support, and patient care solutions are provided. Partnerships with manufacturers, governments, and healthcare providers are leveraged to expand reach. State-of-the-art technology and logistics, including cold chain solutions, are utilized to bridge healthcare gaps in 13 markets.
- Headquarters Singapore, Singapore
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website zuelligpharma.com
- Social LinkedIn
- Legal Name Zuellig Pharma Holdings
- Date of Incorporation 02 Mar, 2015
- Jurisdiction Bhiwandi, Maharashtra, India
- Indian entity revenue₹11.78 Cr
FY 2025 · 0% YoY
- Indian entity net profit₹77.6 Lakh
FY 2025 · 7% margin
- Indian entity EBITDA₹1.42 Cr
FY 2025 · 12% margin
- Investors
- Investments & AcquisitionsAlliance Pharma Cambodge
& 3 more
Associated legal entities of Zuellig Pharma
Zuellig Pharma operates through Zuellig Pharma Specialty Solutions (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zuellig Pharma Specialty Solutions (India) Private Limited CIN U74120MH2015FTC262353 | Active | 02 Mar 2015 | Bhiwandi, Maharashtra | ₹11.8 Cr | 4 | View details |
Products & Services of Zuellig Pharma
Zuellig Pharma offers a comprehensive portfolio of products and services, including eZRx+, Clinical Trial Support, and Patient Care Solutions.
B2B healthcare platform launched for efficient distribution solutions.
Support for clinical trials with advanced logistics infrastructure.
Digital solutions prioritizing patient safety and healthcare management.
Funding Insights of Zuellig Pharma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Zuellig Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2007 | Unspecified | – | Temasek | – |
1 investors in total: 1 institutional.
Investors in Zuellig Pharma
Zuellig Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Temasek.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore |
Investor details for Zuellig Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Zuellig Pharma Specialty Solutions (India) Private Limited (Zuellig Pharma)
Zuellig Pharma Specialty Solutions (India) Private Limited is the primary company behind Zuellig Pharma. The board of Zuellig Pharma Specialty Solutions (India) Private Limited currently have 4 directors; the longest-serving is Giuseppe Leo, appointed in 2015. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Giuseppe Leo DIN 07066764 | Director | 03 Mar 2015 | 11 yrs 8 mo | Zuellig Pharma Specialty Solutions (India) Private Limited |
| Dharmesh Jayendrakumar Parikh DIN 09231845 | Director | 16 Jul 2021 | 5 yrs 3 mo | Zuellig Pharma Specialty Solutions (India) Private Limited |
| Evasio Barbero DIN 09465944 | Director | 14 Jan 2022 | 4 yrs 9 mo | Zuellig Pharma Specialty Solutions (India) Private Limited |
| Chee Peng Lim DIN 09844025 | Director | 21 Feb 2023 | 3 yrs 8 mo | Zuellig Pharma Specialty Solutions (India) Private Limited |
People of Zuellig Pharma
21 people are tracked at Zuellig Pharma (6 in leadership, 15 in team).
| Name | Role | Group |
|---|---|---|
John Graham | CEO | Leadership |
Louis-Georges LASSONNERY | Managing Director | Leadership |
Winnie Cho | Head Of Trade And Consumer Healthcare | Leadership |
Ivy Ng | Director, Head Of Strategic Partnerships & Business Development, Malaysia And Brunei | Leadership |
Andrew Khoo | Chief Financial Officer - Malaysia & Brunei | Leadership |
Aiza A. | Talent Acquisition Lead & HR Business Partner Malaysia & Brunei | Leadership |
Amirullah Ehsan | Account Receivable Specialist | Team |
Phoebe Lim | Market Lead, Clinical Reach | Team |
Serene Ho | Senior Product Specialist | Team |
Lalitha Kalyanasundaran | Senior Manager | Team |
Louis Ong | Business Manager | Team |
Shweta Shrivastava | Regional Business Development And Analytics Manager- Asia | Team |
Usha Nanthini S.rajasegaran | Executive Customer Experience (medical Device) | Team |
Kanmani Kuppusamy | Talent & Learning And Development | Team |
Syahmi Iskandar Norli | Training Manager (trade/ Retail/ Consumer Healthcare) Mysgbn | Team |
Honey Ho | Regional Legal Counsel | Team |
Lee Chiew Ho | Senior Facilities Manager | Team |
Christine Wong | Finance Executive | Team |
Wilson Chong | Senior Warehouse Manager | Team |
Jonathan Yong | Senior Brand Manager | Team |
1 more people are available in the full profile.
Complete people profiles for Zuellig Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Zuellig Pharma
Figures of Zuellig Pharma Specialty Solutions (India) Private Limited, the primary company behind Zuellig Pharma, for FY 2025. Revenue was ₹11.78 Cr (0% year on year). Net profit was ₹77.6 Lakh (7% margin). EBITDA was ₹1.42 Cr (12% margin). Revenue has grown at a compounded annual rate of +33% over three years and +16% over five years.
- ₹11.78 CrRevenue · FY 2025 · 0% YoY
- ₹77.6 LakhNet profit · 7% margin
- ₹1.42 CrEBITDA · 12% margin
- ₹39.4 LakhPaid-up capital
- +33%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Zuellig Pharma Specialty Solutions (India) Private Limited are on its company page.
Detailed financial statements for Zuellig Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zuellig Pharma
Zuellig Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alliance Pharma Cambodge, Klinify and MiCare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Multivitamins for children are manufactured in syrup and drops formats. | propan.com.ph | Paranaque, Philippines | 0 | Jan 2025 | •••• | |
Pharmaceutical products are distributed and stored in Cambodia. | alliancepharma.biz | Phnom Penh, Cambodia | 2001 | Mar 2020 | •••• | |
Patient records are managed through a cloud-based platform for clinics. | klinify.com | Singapore | 2011 | Jun 2019 | •••• | |
Third-party administration services are provided in Malaysia. | micaresvc.com | Shah Alam, Malaysia | 2006 | Jun 2013 | •••• |
Complete acquisition details for Zuellig Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zuellig Pharma
6 dated milestones of Zuellig Pharma across 33 years, from founding to its latest funding, stage changes and deals.
- Founded Zuellig Pharma is founded.
- Funding First funding round.
- Acquisition Acquires MiCare.
- Acquisition Acquires Klinify.
- Acquisition Acquires Alliance Pharma Cambodge.
- Acquisition Acquires Propan.
Web traffic of Zuellig Pharma
The website of Zuellig Pharma (zuelligpharma.com) receives about 70.4K visits a month and ranks #624,096 among all websites worldwide, #678 in Biotechnology and Pharmaceuticals.
- Monthly visits70.4K
▲ 58.7% vs previous month
- Unique visitors12.7K
per month
- Global rank#624,096
among all websites
- Category rank#678
Health · Biotechnology and Pharmaceuticals
- Bounce rate33%
- Pages per visit3.2
- Average visit1 min 40 sec
- DevicesDesktop 64% · Mobile 36%
Websites whose visitors overlap most with Zuellig Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| pharmaceutical-business-review.com | 100% | #2,626,966 | View details | ||
| novartis.com | 83% | 948.8K | #58,822 | View details | |
| tablettingscience.com | 78% | View details | |||
| eisai.com | 74% | 74.5K | #534,857 | View details | |
| servier.com | 74% | 306.8K | #150,173 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Zuellig Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zuellig Pharma
Complete news archive for Zuellig Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zuellig Pharma
Zuellig Pharma was founded in 1992 and raised its 1st funding round 15 years after it was founded.
Zuellig Pharma is headquartered in Singapore, Singapore.
John Graham is the CEO of Zuellig Pharma, as recorded in our data.
The primary company behind Zuellig Pharma, Zuellig Pharma Specialty Solutions (India) Private Limited, reported revenue of ₹11.78 Cr for FY 2025, down 0% year on year.
Healthcare access across Asia is facilitated by Zuellig Pharma through integrated solutions. The company operates in pharmaceuticals, medical devices, consumer healthcare, vaccines, animal health, and specialty care. Innovative distribution, commercialization, clinical trial support, and patient care solutions are provided. Partnerships with manufacturers, governments, and healthcare providers are leveraged to expand reach. State-of-the-art technology and logistics, including cold chain solutions, are utilized to bridge healthcare gaps in 13 markets.
Zuellig Pharma offers eZRx+, Clinical Trial Support, and Patient Care Solutions.
Zuellig Pharma has made 4 acquisitions, including Alliance Pharma Cambodge, Klinify, and MiCare.
Zuellig Pharma has 1 investor. Key investors include Temasek.
Zuellig Pharma operates through Zuellig Pharma Specialty Solutions (India) Private Limited.
The legal entities of Zuellig Pharma currently have 4 directors, including Evasio Barbero, Giuseppe Leo, Dharmesh Jayendrakumar Parikh and others.